| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 225,017 | 254,458 | 245,521 | 248,023 | | Cost of Revenue | 43,825 | 48,007 | 49,895 | 50,307 | | | Gross Profit |
-
| 206,451 | 195,626 | 197,716 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 98,381 | 106,372 | 104,909 | 99,298 | | Non Recurring |
-
| (3,040) | 3,040 | 90,000 | | Others | 32,405 | 65,458 | 51,463 | 95,115 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 37,661 | 36,214 | (86,697) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 50,406 | 37,661 | 36,214 | (86,697) | | Interest Expense | 21,235 | 22,146 | 21,556 | 26,425 | | Income Before Tax | 29,171 | 15,515 | 14,658 | (113,122) | | Income Tax Expense | 5,825 | 2,404 | 1,573 | (11,255) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 23,346 | 13,111 | 13,085 | (101,867) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,346 | 13,111 | 13,085 | (101,867) | | Preferred Stock And Other Adjustments | (5,046) | (5,046) | (5,031) | (463) | | | Net Income Applicable To Common Shares | $18,300 | $8,065 | $8,054 | ($102,330) |
|
0.51% Nasdaq 
Income Statement
